Teva Pharmaceuticals USA, Inc recalls
Every recall we track for Teva Pharmaceuticals USA, Inc — 85 in all, from 2012–2026 — plus the complaints and injury reports the public filed about them. 5 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Teva Pharmaceuticals USA, Inc peaked in 2022 (11); 53 since 2017. 6% rated “stop using now”.
All FDA recall records for Teva Pharmaceuticals USA, Inc since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 1 | 0 | 1 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 1 | 6 | 3 | 11 |
| 2023 | 1 | 0 | 5 | 4 | 10 |
| 2024 | 0 | 0 | 7 | 1 | 8 |
| 2025 | 1 | 0 | 6 | 0 | 7 |
| 2026 (to date) | 0 | 2 | 5 | 9 | 16 |
Teva Pharmaceuticals USA, Inc recalls before 2017
Recalls on record by year.
Most common reasons for Teva Pharmaceuticals USA, Inc recalls
What to do if you have a recalled Teva Pharmaceuticals USA, Inc product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Teva Pharmaceuticals USA, Inc recalls
60 shown- Use cautionDrug
Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals,
Teva Pharmaceuticals recalls specific lots of 5 mg Metoclopramide tablets due to the presence of foreign tablets and capsules. Check your bottle's lot number.
Teva PharmaceuticalsSep 29, 2026 - UnratedDrug
Teva Pharmaceuticals USA, Inc recalls traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o,
Teva Pharmaceuticals recalls 50mg traZODone tablets manufactured in Croatia due to foreign tablets present. Consumers should contact Teva for details.
TevaAug 24, 2026 - UnratedDrug
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing:
Teva recalls Octreotide Acetate 30mg single-dose kits due to lack of sterility assurance from FDA inspection. Affected kits have specific NDC codes and lot numbers. No remedy provided in recall notice.
TevaApr 24, 2026 - UnratedDrug
Teva Pharmaceuticals USA, Inc recalls Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister
Teva Pharmaceuticals recalls specific lots of Claravis 10mg capsules due to failed impurity specifications. Check your lot numbers and expiration date.
TevaApr 6, 2026 - UnratedDrug
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only,
Teva recalls Clonidine Transdermal System due to use of unapproved raw material. Affected units have specific NDC numbers and expiration dates. Consumers should contact Teva for details.
TevaMar 19, 2026 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial in Kit, Rx
Teva recalls Octreotide Acetate 20mg vials due to potential lack of sterility from manufacturing quality issues. Affected lots expire 9/31/2026 or 3/31/2027.
TevaMar 17, 2026 - Use cautionDrug
Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles
Teva Pharmaceuticals recalls specific lots of Metoprolol Succinate Extended-Release Tablets, 50 mg, due to failed dissolution specifications. Check your bottle's NDC and lot number.
Teva PharmaceuticalsJan 29, 2026 - UnratedDrug
Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA,
Teva Pharmaceuticals recalls 40mg Isotretretinoin capsules due to superpotent and subpotent risks. Affected lots have specific expiration dates and packaging identifiers.
TevaJan 12, 2026 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by:
Teva Pharmaceuticals recalls Testosterone Gel 1% (2.5g doses) due to defective container causing leakage. This may lead to product contamination. Affected units have specific lot numbers and expiration dates.
Teva PharmaceuticalsNov 7, 2025 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx
Teva Pharmaceuticals recalls specific amoxicillin-clavulanate oral suspension due to subpotent clavulanate potassium. This may result in ineffective treatment for bacterial infections. Consumers should contact the manufacturer for details.
TevaOct 13, 2025 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA
Teva Pharmaceuticals recalls 2mg Prazosin capsules with N-nitroso impurity levels above safety limits. Consumers should check NDC numbers and expiration dates for affected lots.
TevaOct 7, 2025 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb,
Teva recalls 100-count Metoclopramide 10mg tablets due to foreign tablets/capsules. Rx-only medication manufactured in Croatia. Check NDC 0093-2203-01 and lot 5420094.
Teva PharmaceuticalsMay 23, 2025 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged as a) 1 syringe in 1 CARTON,
Teva Pharmaceuticals recalls Granix (tbo-filgrastim) injection due to stability test failure. This may affect medication safety. Check product details to see if you have recalled items.
TevaJan 10, 2025 - UnratedDrug
Teva Pharmaceuticals USA, Inc recalls Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva Pharmaceuticals, USA, Inc. North Wales,
Teva Pharmaceuticals recalls 1.62% testosterone gel with alcohol 80% v/v due to superpotent drug risk. Affected units have specific NDC numbers and expiration dates. Consumers should contact Teva for details.
TevaAug 8, 2024 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc.,
Teva Pharmaceuticals recalls 0.1mg fludrocortisone tablets due to impurities exceeding safety limits. Affected lots manufactured in Canada expire 2024. Consumers should check NDC 0555-0997-02 for details.
TevaJun 28, 2024 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in
Teva recalls 20-count chewable amoxicillin-clavulanate tablets due to subpotent drug content. This means the medication may not be as effective as labeled. Consumers should contact Teva for details.
TevaJun 4, 2024 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva
Teva recalls 40mg Isotretretinoin capsules due to potential stability issues affecting drug potency. Learn about affected lots and what to do.
TevaMar 28, 2024 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3
Teva recalls Tri-Lo-Sprintec birth control tablets due to failed dissolution specifications. This may affect product effectiveness. Check NDC 0093-2140-62 and lot numbers for affected items.
TevaMar 7, 2024 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister
Teva recalls Nortrel 0.5/35 tablets with discolored (blue) tablets mixed in. Affected units have specific NDC and lot numbers. Stop using if you see discoloration.
TevaJan 25, 2024 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort
Teva Pharmaceuticals recalls 9mg Budesonide Extended-Release Tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact for return instructions.
TevaJan 8, 2024 - Lower riskDrug
Teva Pharmaceuticals USA, Inc recalls Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva
Teva Pharmaceuticals recalls 1.62% testosterone gel with OOS viscosity. This may affect product stability. Consumers should check NDC 0591-2926-30 and lot number 100029472.
TevaNov 10, 2023 - Lower riskDrug
Teva Pharmaceuticals USA Inc recalls Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc.,
Teva recalls 12.5 mg Sunitinib Malate capsules due to moisture content exceeding specifications. This may affect product stability and safety for patients requiring this medication.
TevaJul 5, 2023 - UnratedDrug
Teva Pharmaceuticals USA Inc recalls Fentanyl Buccal Tablets CII, 600mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only,
Teva Pharmaceuticals recalls Fentanyl Buccal Tablets (600mcg) due to missing or incorrect package inserts. This could lead to improper use. Affected units include specific lots from Mayne Pharma.
Teva PharmaceuticalsApr 27, 2023 - UnratedDrug
Teva Pharmaceuticals USA Inc recalls Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva
Teva recalls Montelukast Sodium Oral Granules 4mg (30-pack) due to failed impurities. This may pose health risks. Contact Teva for details.
TevaMar 27, 2023 - UnratedDrug
Teva Pharmaceuticals USA Inc recalls Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%,
Teva recalls Clear Eyes allergy eye drops due to impurities found in stability testing. Affected lots expire May 2023 through February 2024. No remedy specified in recall notice.
Teva PharmaceuticalsFeb 23, 2023 - Stop using nowDrug
Teva Pharmaceuticals USA Inc recalls Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, RX only, Manufactured by: Actavis
Teva Pharmaceuticals recalls specific lots of Metformin hydrochloride Extended-Release Tablets due to elevated NDMA levels exceeding safety limits.
Teva PharmaceuticalsFeb 22, 2023 - Lower riskDrug
Teva Pharmaceuticals USA Inc recalls Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed
Teva Pharmaceuticals recalls 100-count amphetamine tablets labeled 15mg but containing 20mg tablets. This label error may lead to incorrect dosing. Consumers should check their bottles for the specific lot number.
TevaAug 29, 2022 - Stop using nowDrug
Teva Pharmaceuticals USA Inc recalls Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North
Teva recalls Neomycin Sulfate 500mg tablets due to teflon contamination in the active ingredient. Affected lots expire 10/2024. Stop using immediately.
TevaAug 23, 2022 - Lower riskDrug
Teva Pharmaceuticals USA Inc recalls Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint
Teva Pharmaceuticals recalls Azacitidine 100mg/vial lyophilized powder (Rx only) manufactured in Romania due to subpotent drug results from stability testing. This may affect medication effectiveness.
Teva PharmaceuticalsJul 22, 2022 - Lower riskDrug
Teva Pharmaceuticals USA Inc recalls Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by:
Teva Pharmaceuticals recalls Matzim LA 240mg extended-release tablets due to failed dissolution specifications. This may affect medication effectiveness. Check your product details to see if you need to take action.
Teva PharmaceuticalsJul 21, 2022 - Use cautionDrug
Teva Pharmaceuticals USA Inc recalls Testosterone Gel 1% (25mg testosterone/2.5g of gel) 2.5 g per unit dose, Rx Only, 30 unit-dose packets per box.
Teva Pharmaceuticals recalls specific lots of Testosterone Gel 1% due to out-of-specification assay results. Check your lot number and expiration date.
Teva PharmaceuticalsJun 29, 2022 - Lower riskDrug
Teva Pharmaceuticals USA Inc recalls Tretinoin Capsules, 10 mg, Rx Only, 100 capsules per bottle, Teva Pharmaceuticals USA Inc., North Wales, PA, 19454, NDC
Teva recalls 10mg Tretinoin Capsules due to failed dissolution testing. This affects specific lots from 2022-2023. Consumers should contact Teva for details.
TevaJun 14, 2022 - UnratedDrug
Teva Pharmaceuticals USA Inc recalls Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02,
Teva Pharmaceuticals recalls Alprostadil Injection USP 500 mcg/mL vials due to impurities found in stability testing. This medication may cause serious injury if used improperly.
TevaMay 18, 2022 - Lower riskDrug
Teva Pharmaceuticals USA Inc recalls Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc.,
Teva recalls 0.5mg Anagrelide Capsules due to failed dissolution testing. This may affect medication effectiveness. Check NDC 0172-5241-60 and lot # GD01090.
TevaMay 11, 2022 - UnratedDrug
Teva Pharmaceuticals USA Inc recalls Lidocaine 2.5% and Prilocaine 2.5% Cream, USP, packaged in a) 5 g tubes (NDC 0591-2070-72), b) 30 g tubes (NDC
Teva Pharmaceuticals recalls Lidocaine 2.5% and Prilocaine 2.5% Cream due to cGMP deviations. Products sold in 5g and 30g tubes with specific lot numbers and expiration dates.
Teva PharmaceuticalsApr 15, 2022 - UnratedDrug
Teva Pharmaceuticals USA Inc recalls IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva
Teva recalls IDArubicin Hydrochloride Injection 5mL vials due to silica and iron oxide particles. This may cause serious complications if injected. Contact Teva for details.
TevaMar 29, 2022 - Lower riskDrug
Teva Pharmaceuticals USA, Inc. recalls Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL (3.4 fl. oz.) bottle, Rx only, Manufactured for:
Teva Pharmaceuticals recalls Valganc: 50 mg/mL oral solution with brown/black particles detected during testing. This medication is prescription-only and may be unsafe for patients.
Teva PharmaceuticalsNov 4, 2019 - UnratedDrug
Teva Pharmaceuticals USA, Inc. recalls Fluconazole Oral Suspension, 10 mg/mL, 35 ml bottle, RX only, Mfd by Cipla, Ltd., Goa, India, Dist by Teva
Teva Pharmaceuticals recalls Fluconazole Oral Suspension, 10 mg/mL, because it failed stability specifications for preservative content. Check your lot numbers.
Teva PharmaceuticalsNov 14, 2013 - Stop using nowDrug
Teva Pharmaceuticals USA, Inc. recalls Valacyclovir Hydrochloride Tablets, 1 g, 30 count bottle, Rx only manufactured in Israel by Teva Pharmaceuticals Ind.,
Teva Pharmaceuticals recalls 7,020 bottles of Valacyclovir 1g tablets due to potential Pravastatin fragments. Check your lot number W22042.
Teva PharmaceuticalsNov 8, 2013 - Stop using nowDrug
Teva Pharmaceuticals USA, Inc. recalls CARBOplatin Injection, 600 mg/60ml, MultiDose, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618 NDC
Teva Pharmaceuticals is recalling specific lots of Carboplatin Injection because the required reduction of endotoxin was not met, posing a sterility risk.
Teva PharmaceuticalsAug 13, 2013 - UnratedDrug
Teva Pharmaceuticals USA, Inc. recalls Propranolol Hydrochloride Tablets, USP, 10 mg, Rx Only, 1000 count bottles, Manufactured in Czech Republic by: Teva
Teva Pharmaceuticals is recalling specific lots of Propranolol Hydrochloride 10 mg tablets because some may not meet weight specifications.
TevaAug 6, 2013 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Terazosin Hydrochloride Capsules,10 mg, 100-count bottle, Rx only, Manufactured for Teva Pharmaceuticals USA,
Teva recalls 6,267 bottles of Terazosin Hydrochloride 10mg capsules because the label incorrectly states 10mg while containing 5mg. Check your lot number.
Teva PharmaceuticalsJul 23, 2013 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC
Teva Pharmaceuticals recalls specific lots of Amoxicillin for Oral Suspension due to orange to brown discoloration on inner foil seals.
Teva PharmaceuticalsJun 18, 2013 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Methylphenidate Hydrochloride Extended-Release Capsules (LA), 40 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS
Teva Pharmaceuticals is recalling 40 mg extended-release capsules due to failed dissolution specifications. Check your lot numbers and expiration dates.
Teva PharmaceuticalsJun 18, 2013 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Actiq (oral transmucosal fentanyl citrate) 200 mcg, lozenge on a stick, a)Single Blister (NDC 63459-502-01), b) 30
Teva Pharmaceuticals recalls specific lots of Actiq 200 mcg lozenges because they failed dissolution specifications during stability testing.
TevaMay 28, 2013 - UnratedDrug
Teva Pharmaceuticals USA, Inc. recalls Amoxicillin for Oral Suspension, USP 400mg/5mL, NDC 0093-4161-78 (75ml) and 0093-4161-73 (100mL)
Teva recalls Amoxicillin Oral Suspension due to yellow to brown discoloration on inner foil seals. Check lot numbers and expiration dates for affected bottles.
Teva PharmaceuticalsApr 26, 2013 - Lower riskDrug
Teva Pharmaceuticals USA, Inc. recalls Disulfiram Tablets USP 250 mg, 100 tablet bottle, Rx only, Manufactured for TEVA Pharmaceuticals, USA, Sellersville, PA
Teva Pharmaceuticals recalls 68,322 bottles of Disulfiram Tablets USP 250 mg due to a manufacturing deviation where cotton coils are missing from some packages.
Teva PharmaceuticalsMar 19, 2013 - UnratedDrug
Teva Pharmaceuticals USA, Inc. recalls Junel(TM) Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), 28 day
Teva Pharmaceuticals recalls specific lots of Junel Fe 1.5/30 birth control pills due to a failed impurity specification involving NBBS.
Teva PharmaceuticalsMar 15, 2013 - UnratedDrug
Teva Pharmaceuticals USA, Inc. recalls Errin (norethindrone tablets, USP), 0.35 mg, 6 blister cards per carton, 28 tablets each, 28 day regimen, Rx Only, Teva
Teva Pharmaceuticals recalls Errin (norethindrone) tablets due to failed impurity specifications. Check lot numbers and expiration dates for affected batches.
TevaMar 15, 2013 - UnratedDrug
Teva Pharmaceuticals USA, Inc. recalls Seasonale(R) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg, 3 extended-cycle tablet dispensers, 91
Teva Pharmaceuticals recalls specific lots of Seasonale birth control tablets due to a failed impurity specification. Check your lot numbers and expiration dates.
TevaMar 14, 2013 - UnratedDrug
Teva Pharmaceuticals USA, Inc. recalls Jolessa (levonorgestrel/ethinyl estradiol) Tablets, 0.15 mg/0.03 mg, 91-count tablets per extended-cycle tablet
Teva Pharmaceuticals recalls Jolessa tablets due to out-of-specification appearance. Check lot numbers and expiration dates for affected units.
Teva PharmaceuticalsMar 12, 2013 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC
Teva Pharmaceuticals recalls specific lots of Cefdinir for Oral Suspension due to improperly sealed bottles. Check your NDC and lot numbers.
Teva PharmaceuticalsFeb 26, 2013 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA
Teva Pharmaceuticals recalls specific lots of Clonazepam 0.5mg orally disintegrating tablets due to failed content uniformity specifications.
TevaFeb 7, 2013 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles
Teva Pharmaceuticals recalls specific lots of Terazosin Hydrochloride 2 mg capsules due to the presence of foreign tablets. Check your bottle NDC and lot number.
Teva PharmaceuticalsJan 23, 2013 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Copaxone (glatiramer acetate injection), 20 mg/1 mL, packaged in 30 single use PRE-FILLED syringes and 33 Alcohol Preps
Teva Pharmaceuticals recalls specific lots of Copaxone injection due to visible silicone oil. Check your lot number and expiration date for details.
TevaDec 5, 2012 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30
Teva Pharmaceuticals is recalling specific lots of Copaxone (glatiramer acetate) injections due to the presence of a foreign particle.
TevaMay 18, 2012 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals
Teva Pharmaceuticals recalls 2,268 bottles of Metoprolol Tartrate 50mg tablets due to potential weight specification deviations. Check your lot number.
Teva PharmaceuticalsMay 16, 2012 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Zeosa (norethindrone and ethinyl estradiol tablets USP, (chewable), 0.4 mg/0.035 mg, and ferrous fumarate tablets USP,
Teva Pharmaceuticals is recalling specific lots of Zeosa chewable tablets due to potential impurities. Check your lot numbers and expiration dates for details.
TevaMay 2, 2012 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA
Teva Pharmaceuticals recalls 13,232 bottles of Cabergoline 0.5mg tablets due to potential impurities exceeding specifications over shelf life.
Teva PharmaceuticalsApr 24, 2012 - Use cautionDrug
Teva Pharmaceuticals USA, Inc. recalls Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day
Teva Pharmaceuticals recalls Jolessa contraceptive tablets because some packages may lack placebo pills, potentially affecting regimen effectiveness.
TevaApr 23, 2012
Teva Pharmaceuticals USA, Inc recall questions
How many recalls has Teva Pharmaceuticals USA, Inc had?
85 recalls from Teva Pharmaceuticals USA, Inc are on record with U.S. safety agencies, from 2012–2026.
What is the most recent Teva Pharmaceuticals USA, Inc recall?
Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals,, dated Sep 29, 2026. Every Teva Pharmaceuticals USA, Inc recall is listed on this page, newest first.
Why are Teva Pharmaceuticals USA, Inc products recalled?
The most common reasons on record: Failed Dissolution Specifications (6); Labeling: Incorrect or Missing Package Insert (5); CGMP Deviations: use of an unapproved raw material (3); Failed Dissolution Specifications: below specification limits for dissolution. (2).
What should I do if I have a recalled Teva Pharmaceuticals USA, Inc product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Teva Pharmaceuticals USA, Inc recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.